This review provides updated recommendations for the pharmacologic management of systolic heart failure for acute care providers.
May guide acute systolic HF care; leaves open need for prospective outcome validation.
Heart failure is a leading cause of morbidity and mortality. It affects over 5 million patients annually. There are an estimated 400,000-700,000 new cases diagnosed each year. The management of heart failure has changed significantly over the last decade. This review focuses on the pharmacologic management of systolic heart failure, and provides current recommendations for the practicing acute care provider.
No takes yet. Share an insight, caveat, or question.
Prendergast et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: